Long term SARS-CoV-2 infectiousness among three immunocompromised patients: from prolonged viral shedding to SARS-CoV-2 superinfection

Guidelines for stopping COVID-19 patient isolation are mainly symptom-based, with isolation for 10 to 20 days depending on their condition. Here, we describe three deeply immunocompromised patients, each with different clinical evolutions. Asymptomatic carriage, symptom resolution, or superinfection...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Infect Dis
Egile Nagusiak: Tarhini, Hassan, Recoing, Amélie, Bridier-Nahmias, Antoine, Rahi, Mayda, Lambert, Céleste, Martres, Pascale, Lucet, Jean-Christophe, Rioux, Christophe, Bouzid, Donia, Lebourgeois, Samuel, Descamps, Diane, Yazdanpanah, Yazdan, Le Hingrat, Quentin, Lescure, François-Xavier, Visseaux, Benoit
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2021
Gaiak:
Brief Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7928754/
https://ncbi.nlm.nih.gov/pubmed/33556961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiab075
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak